Bank of Montreal’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-25,000
Closed -$253K 3839
2022
Q4
$253K Sell
25,000
-4,150
-14% -$41.3K ﹤0.01% 3026
2022
Q3
$287 Buy
29,150
+4,150
+17% +$40.8K ﹤0.01% 2961
2022
Q2
$245 Hold
25,000
﹤0.01% 3135
2022
Q1
$244K Hold
25,000
﹤0.01% 3323
2021
Q4
$244K Sell
25,000
-95,000
-79% -$927K ﹤0.01% 2865
2021
Q3
$1.17M Sell
120,000
-25,591
-18% -$248K ﹤0.01% 2387
2021
Q2
$1.41M Buy
+145,591
New +$1.41M ﹤0.01% 2276

Other funds holding COCH

Bank of Montreal's COCH Position: Q1 2023 in Review

Bank of Montreal sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 25,000 shares — an estimated $253K sold.

Bank of Montreal first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $1.41M in Q2 2021. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Bank of Montreal reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Bank of Montreal sold 25,000 Envoy Medical shares in Q1 2023, an estimated $253K.
  • Bank of Montreal first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
  • Bank of Montreal's Envoy Medical position peaked at $1.41M in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.